Literature DB >> 17509459

The neuropharmacology of the ketogenic diet.

Adam L Hartman1, Maciej Gasior, Eileen P G Vining, Michael A Rogawski.   

Abstract

The ketogenic diet is a valuable therapeutic approach for epilepsy, one in which most clinical experience has been with children. Although the mechanism by which the diet protects against seizures is unknown, there is evidence that it causes effects on intermediary metabolism that influence the dynamics of the major inhibitory and excitatory neurotransmitter systems in brain. The pattern of protection of the ketogenic diet in animal models of seizures is distinct from that of other anticonvulsants, suggesting that it has a unique mechanism of action. During consumption of the ketogenic diet, marked alterations in brain energy metabolism occur, with ketone bodies partly replacing glucose as fuel. Whether these metabolic changes contribute to acute seizure protection is unclear; however, the ketone body acetone has anticonvulsant activity and could play a role in the seizure protection afforded by the diet. In addition to acute seizure protection, the ketogenic diet provides protection against the development of spontaneous recurrent seizures in models of chronic epilepsy, and it has neuroprotective properties in diverse models of neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509459      PMCID: PMC1940242          DOI: 10.1016/j.pediatrneurol.2007.02.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  101 in total

1.  A neuropharmacological evaluation of felbamate as a novel anticonvulsant.

Authors:  H S White; H H Wolf; E A Swinyard; G A Skeen; R D Sofia
Journal:  Epilepsia       Date:  1992 May-Jun       Impact factor: 5.864

2.  Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in maximal electroshock seizure.

Authors:  W Fischer; M Müller
Journal:  Biomed Biochim Acta       Date:  1988

3.  [Effect of ketogenic diet on the convulsive threshold and brain amino acid and monoamine levels in young mice].

Authors:  K Otani; A Yamatodani; H Wada; T Mimaki; H Yabuuchi
Journal:  No To Hattatsu       Date:  1984

4.  Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.

Authors:  W Löscher; D Hönack; C Rundfeldt
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

5.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively.

Authors:  C Hemingway; J M Freeman; D J Pillas; P L Pyzik
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

6.  Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures.

Authors:  Kinga K Borowicz; Marek Zadrozniak; Mariusz Swiader; Aneta Kowalska; Zdzisław Kleinrok; Stanisław J Czuczwar
Journal:  Eur J Pharmacol       Date:  2002-08-02       Impact factor: 4.432

7.  Ketogenic diet: does acetone stop seizures?

Authors:  Sergei S Likhodii; W McIntyre Burnham
Journal:  Med Sci Monit       Date:  2002-08

8.  Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist.

Authors:  Rafal M Kaminski; Madhumita Banerjee; Michael A Rogawski
Journal:  Neuropharmacology       Date:  2004-06       Impact factor: 5.250

9.  Neuronal-glial interactions in rats fed a ketogenic diet.

Authors:  Torun Margareta Melø; Astrid Nehlig; Ursula Sonnewald
Journal:  Neurochem Int       Date:  2006-03-20       Impact factor: 3.921

10.  Epilepsy and the ketogenic diet: assessment of ketosis in children using breath acetone.

Authors:  Kathy Musa-Veloso; Exequiel Rarama; Felix Comeau; Rosalind Curtis; Stephen Cunnane
Journal:  Pediatr Res       Date:  2002-09       Impact factor: 3.756

View more
  76 in total

Review 1.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

2.  Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity.

Authors:  Xinxin Yang; Baohua Cheng
Journal:  J Mol Neurosci       Date:  2010-03-24       Impact factor: 3.444

Review 3.  The ketogenic diet in a pill: is this possible?

Authors:  Jong M Rho; Raman Sankar
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 4.  The ketogenic diet: proposed mechanisms of action.

Authors:  Kirk Nylen; Sergei Likhodii; W McIntyre Burnham
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 5.  Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Authors:  Susan A Masino; Jonathan D Geiger
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

Review 6.  Are therapeutic diets an emerging additional choice in autism spectrum disorder management?

Authors:  M Gogou; G Kolios
Journal:  World J Pediatr       Date:  2018-05-30       Impact factor: 2.764

Review 7.  The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies.

Authors:  T Hu; L A Bazzano
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-01-02       Impact factor: 4.222

8.  A ketogenic diet reduces long-term potentiation in the dentate gyrus of freely behaving rats.

Authors:  Jessica L Koranda; David N Ruskin; Susan A Masino; J Harry Blaise
Journal:  J Neurophysiol       Date:  2011-05-25       Impact factor: 2.714

9.  Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats.

Authors:  David N Ruskin; Tracey A C S Suter; Jessica L Ross; Susan A Masino
Journal:  J Pain       Date:  2013-03-15       Impact factor: 5.820

10.  Methyl ethyl ketone blocks status epilepticus induced by lithium-pilocarpine in rats.

Authors:  Osamu Inoue; Eriko Sugiyama; Nobuyoshi Hasebe; Noriko Tsuchiya; Rie Hosoi; Masatoshi Yamaguchi; Kohji Abe; Antony Gee
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.